Literature DB >> 23089164

Association of intrauterine and early life factors with uterine leiomyomata in black women.

Lauren A Wise1, Rose G Radin, Julie R Palmer, Lynn Rosenberg.   

Abstract

PURPOSE: Uterine leiomyomata (UL) are the primary indication for hysterectomy and are 2-3 times more common in black than white women. Previous studies indicate that early life may be a critical time window of susceptibility to UL. We assessed the association of UL with selected intrauterine and early life factors, expanding on previous research by using a prospective design and validated data on exposure and disease.
METHODS: During 1997-2009, we followed 23,505 premenopausal women aged 23-50 years for new diagnoses of UL in the Black Women's Health Study. We used Cox regression models to compute incidence rate ratios (IRR) and 95% confidence intervals, adjusting for potential confounders.
RESULTS: During 12 years of follow-up, there were 7268 incident UL cases diagnosed by ultrasound (n = 5727) or surgery (n = 1541). There was little evidence of an association between UL and birth weight, gestational age, or exposure to soy formula in infancy. Significant associations were found for being first born, foreign born, or exposed to passive smoke in childhood, but the associations were weak, with IRRs ranging from 1.06 to 1.12.
CONCLUSIONS: These findings do not support the hypothesis that intrauterine and early life factors are strongly related to UL risk.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23089164      PMCID: PMC3508399          DOI: 10.1016/j.annepidem.2012.09.006

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  35 in total

1.  The Black Women's Health Study: a follow-up study for causes and preventions of illness.

Authors:  L Rosenberg; L Adams-Campbell; J R Palmer
Journal:  J Am Med Womens Assoc (1972)       Date:  1995 Mar-Apr

2.  Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study.

Authors:  Lauren A Wise; Julie R Palmer; Elizabeth A Stewart; Lynn Rosenberg
Journal:  Obstet Gynecol       Date:  2005-03       Impact factor: 7.661

3.  In utero exposures and the incidence of endometriosis.

Authors:  Stacey A Missmer; Susan E Hankinson; Donna Spiegelman; Robert L Barbieri; Karin B Michels; David J Hunter
Journal:  Fertil Steril       Date:  2004-12       Impact factor: 7.329

4.  Variation in the incidence of uterine leiomyoma among premenopausal women by age and race.

Authors:  L M Marshall; D Spiegelman; R L Barbieri; M B Goldman; J E Manson; G A Colditz; W C Willett; D J Hunter
Journal:  Obstet Gynecol       Date:  1997-12       Impact factor: 7.661

Review 5.  Factors in fibroid growth.

Authors:  J Andersen
Journal:  Baillieres Clin Obstet Gynaecol       Date:  1998-06

6.  Risk of benign gynecologic tumors in relation to prenatal diethylstilbestrol exposure.

Authors:  Lauren A Wise; Julie R Palmer; Kathleen Rowlings; Raymond H Kaufman; Arthur L Herbst; Kenneth L Noller; Linda Titus-Ernstoff; Rebecca Troisi; Elizabeth E Hatch; Stanley J Robboy
Journal:  Obstet Gynecol       Date:  2005-01       Impact factor: 7.661

7.  Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis.

Authors:  K H Kjerulff; P Langenberg; J D Seidman; P D Stolley; G M Guzinski
Journal:  J Reprod Med       Date:  1996-07       Impact factor: 0.142

8.  Correlation of estrogen levels between successive pregnancies.

Authors:  L Bernstein; L Lipworth; R K Ross; D Trichopoulos
Journal:  Am J Epidemiol       Date:  1995-09-15       Impact factor: 4.897

9.  Relationships of age and reproductive characteristics with plasma estrogens and androgens in premenopausal women.

Authors:  J F Dorgan; M E Reichman; J T Judd; C Brown; C Longcope; A Schatzkin; W S Campbell; C Franz; L Kahle; P R Taylor
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1995-06       Impact factor: 4.254

10.  A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata.

Authors:  L M Marshall; D Spiegelman; M B Goldman; J E Manson; G A Colditz; R L Barbieri; M J Stampfer; D J Hunter
Journal:  Fertil Steril       Date:  1998-09       Impact factor: 7.329

View more
  7 in total

1.  Environmental tobacco smoke and risk of late-diagnosis incident fibroids in the Study of Women's Health across the Nation (SWAN).

Authors:  Jason Y Y Wong; Po-Yin Chang; Ellen B Gold; Wesley O Johnson; Jennifer S Lee
Journal:  Fertil Steril       Date:  2016-07-18       Impact factor: 7.329

2.  Early-life factors and endometriosis risk.

Authors:  Kristen Upson; Sheela Sathyanarayana; Delia Scholes; Victoria L Holt
Journal:  Fertil Steril       Date:  2015-07-26       Impact factor: 7.329

Review 3.  Environmental factors, epigenetics, and developmental origin of reproductive disorders.

Authors:  Shuk-Mei Ho; Ana Cheong; Margaret A Adgent; Jennifer Veevers; Alisa A Suen; Neville N C Tam; Yuet-Kin Leung; Wendy N Jefferson; Carmen J Williams
Journal:  Reprod Toxicol       Date:  2016-07-12       Impact factor: 3.143

Review 4.  Current medical treatment of uterine fibroids.

Authors:  Geum Seon Sohn; SiHyun Cho; Yong Man Kim; Chi-Heum Cho; Mee-Ran Kim; Sa Ra Lee
Journal:  Obstet Gynecol Sci       Date:  2018-02-13

Review 5.  Uterine Fibroids and Diet.

Authors:  Andrea Tinelli; Marina Vinciguerra; Antonio Malvasi; Mladen Andjić; Ivana Babović; Radmila Sparić
Journal:  Int J Environ Res Public Health       Date:  2021-01-25       Impact factor: 3.390

6.  The Causal Evidence of Birth Weight and Female-Related Traits and Diseases: A Two-Sample Mendelian Randomization Analysis.

Authors:  Renke He; Rui Liu; Haiyan Wu; Jiaen Yu; Zhaoying Jiang; Hefeng Huang
Journal:  Front Genet       Date:  2022-08-12       Impact factor: 4.772

7.  Soy-Based Infant Formula Feeding and Ultrasound-Detected Uterine Fibroids among Young African-American Women with No Prior Clinical Diagnosis of Fibroids.

Authors:  Kristen Upson; Quaker E Harmon; Donna D Baird
Journal:  Environ Health Perspect       Date:  2015-11-13       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.